Gene · 7022
Papers2,059
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,059
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinorganic Modulators of Ferroptosis: A Review of Recent Findings. | Int J Mol Sci | 2023 | 36835045 | PubTator, text mining | PubMed |
| microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature Review. | Int J Mol Sci | 2023 | 36834933 | PubTator, text mining | PubMed |
| Potential Regulation of miRNA-29 and miRNA-9 by Estrogens in Neurodegenerative Disorders: An Insightful Perspective. | Brain Sci | 2023 | 36831786 | PubTator, text mining | PubMed |
| Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients. | Cancers (Basel) | 2023 | 36831624 | PubTator, text mining | PubMed |
| microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer. | Cancers (Basel) | 2023 | 36831572 | PubTator, text mining | PubMed |
| Differential Expression of AP-2 Transcription Factors Family in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma-A Bioinformatics Study. | Cells | 2023 | 36831334 | PubTator, text mining | PubMed |
| Induction of primordial germ cell-like cells from common marmoset embryonic stem cells by inhibition of WNT and retinoic acid signaling. | Sci Rep | 2023 | 36823310 | PubTator, text mining | PubMed |
| Emerging roles of m6A RNA modification in cancer therapeutic resistance. | Exp Hematol Oncol | 2023 | 36810281 | PubTator, text mining | PubMed |
| CDK4/6 inhibitor palbociclib promotes SARS-CoV-2 cell entry by down-regulating SKP2 dependent ACE2 degradation. | Antiviral Res | 2023 | 36806814 | PubTator, text mining | PubMed |
| Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression. | Elife | 2023 | 36803359 | PubTator, text mining | PubMed |
| In silico discovery of small molecules for efficient stem cell differentiation into definitive endoderm. | Stem Cell Reports | 2023 | 36801003 | PubTator, text mining | PubMed |
| Molecular and cellular evolution of the amygdala across species analyzed by single-nucleus transcriptome profiling. | Cell Discov | 2023 | 36788214 | PubTator, text mining | PubMed |
| PbAP2-FG2 and PbAP2R-2 function together as a transcriptional repressor complex essential for Plasmodium female development. | PLoS Pathog | 2023 | 36780562 | PubTator, text mining | PubMed |
| Expanded Potential Stem Cells from Human Embryos Have an Open Chromatin Configuration with Enhanced Trophoblast Differentiation Ability. | Adv Sci (Weinh) | 2023 | 36775869 | PubTator, text mining | PubMed |
| Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives. | Cancers (Basel) | 2023 | 36765919 | PubTator, text mining | PubMed |
| Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. | Sci Adv | 2023 | 36753549 | PubTator, text mining | PubMed |
| KLF14/miR-1283/TFAP2C axis inhibits HER2-positive breast cancer progression via declining tumor cell proliferation. | Mol Carcinog | 2023 | 36752341 | PubTator, text mining | PubMed |
| Signal-induced enhancer activation requires Ku70 to read topoisomerase1-DNA covalent complexes. | Nat Struct Mol Biol | 2023 | 36747093 | PubTator, text mining | PubMed |
| Host-Erythrocytic Sphingosine-1-Phosphate Regulates Plasmodium Histone Deacetylase Activity and Exhibits Epigenetic Control over Cell Death and Differentiation. | Microbiol Spectr | 2023 | 36744922 | PubTator, text mining | PubMed |
| Resetting histone modifications during human prenatal germline development. | Cell Discov | 2023 | 36737434 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7022/papers?page=17